Modular Medical, Inc. Announces 2024 Annual Meeting of Shareholders
Ticker: MODD · Form: DEF 14A · Filed: Jan 8, 2024 · CIK: 1074871
Complexity: simple
Sentiment: neutral
Topics: proxy statement, annual meeting, shareholder vote, webcast, corporate governance
TL;DR
<b>Modular Medical, Inc. invites shareholders to its 2024 Annual Meeting on February 13, 2024, accessible via webcast, and urges prompt voting.</b>
AI Summary
Modular Medical, Inc. (MODD) filed a Proxy Statement (DEF 14A) with the SEC on January 8, 2024. Modular Medical, Inc. will hold its 2024 Annual Meeting of Shareholders via live audio webcast on February 13, 2024, at 8:00 a.m. Pacific time. Shareholders can attend the meeting online at www.virtualshareholdermeeting.com/MODD2024. The company is filing a Definitive Proxy Statement (DEF 14A) with the SEC. The proxy statement provides information on matters to be considered and acted upon at the meeting. Shareholders are encouraged to vote their shares promptly via Internet, telephone, or mail.
Why It Matters
For investors and stakeholders tracking Modular Medical, Inc., this filing contains several important signals. This filing is a proxy statement, indicating key corporate governance and shareholder voting matters will be addressed. The virtual meeting format suggests a focus on accessibility and potentially cost-efficiency for shareholder engagement.
Risk Assessment
Risk Level: — Modular Medical, Inc. shows moderate risk based on this filing. The filing is a routine proxy statement for an annual meeting, with no immediate financial or operational disclosures that would indicate high risk.
Analyst Insight
Shareholders should review the proxy statement for details on voting matters and participate in the annual meeting.
Key Numbers
- 2024 — Annual Meeting Year (Modular Medical, Inc. 2024 Annual Meeting of Shareholders)
- February 13 — Meeting Date (Annual Meeting to be held on Tuesday, February 13, 2024)
- 8:00 a.m. Pacific time — Meeting Time (Meeting to be held at 8:00 a.m. Pacific time)
Key Players & Entities
- Modular Medical, Inc. (company) — Filer and subject of the proxy statement
- Paul DiPerna (person) — Chairman of the Board of Directors
- Securities and Exchange Commission (regulator) — Recipient of the filing
- February 13, 2024 (date) — Date of the Annual Meeting
- 2024 (date) — Year of the Annual Meeting
FAQ
When did Modular Medical, Inc. file this DEF 14A?
Modular Medical, Inc. filed this Proxy Statement (DEF 14A) with the SEC on January 8, 2024.
What is a DEF 14A filing?
A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by Modular Medical, Inc. (MODD).
Where can I read the original DEF 14A filing from Modular Medical, Inc.?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Modular Medical, Inc..
What are the key takeaways from Modular Medical, Inc.'s DEF 14A?
Modular Medical, Inc. filed this DEF 14A on January 8, 2024. Key takeaways: Modular Medical, Inc. will hold its 2024 Annual Meeting of Shareholders via live audio webcast on February 13, 2024, at 8:00 a.m. Pacific time.. Shareholders can attend the meeting online at www.virtualshareholdermeeting.com/MODD2024.. The company is filing a Definitive Proxy Statement (DEF 14A) with the SEC..
Is Modular Medical, Inc. a risky investment based on this filing?
Based on this DEF 14A, Modular Medical, Inc. presents a moderate-risk profile. The filing is a routine proxy statement for an annual meeting, with no immediate financial or operational disclosures that would indicate high risk.
What should investors do after reading Modular Medical, Inc.'s DEF 14A?
Shareholders should review the proxy statement for details on voting matters and participate in the annual meeting. The overall sentiment from this filing is neutral.
How does Modular Medical, Inc. compare to its industry peers?
Modular Medical, Inc. operates in the medical instruments and apparatus industry, focusing on products for surgical and medical applications.
Are there regulatory concerns for Modular Medical, Inc.?
The filing is made under Section 14(a) of the Securities Exchange Act of 1934, which governs the solicitation of proxies.
Industry Context
Modular Medical, Inc. operates in the medical instruments and apparatus industry, focusing on products for surgical and medical applications.
Regulatory Implications
The filing is made under Section 14(a) of the Securities Exchange Act of 1934, which governs the solicitation of proxies.
What Investors Should Do
- Review the proxy statement for agenda items and voting proposals.
- Register to attend the virtual annual meeting.
- Submit proxy votes via internet, telephone, or mail before the meeting.
Key Dates
- 2024-02-13: Annual Meeting of Shareholders — Shareholders will vote on company matters.
- 2024-01-08: Filing Date — Definitive Proxy Statement filed with the SEC.
Year-Over-Year Comparison
This is a DEF 14A filing for the annual meeting, following standard SEC procedures for shareholder communication.
Filing Stats: 4,345 words · 17 min read · ~14 pages · Grade level 11.9 · Accepted 2024-01-08 06:21:25
Key Financial Figures
- $0.001 — f record of our common stock, par value $0.001 per share, at the close of business on
Filing Documents
- def14a0124_modular.htm (DEF 14A) — 1066KB
- tmodular_logo.jpg (GRAPHIC) — 56KB
- tbarchart_001.jpg (GRAPHIC) — 311KB
- tbarchart_002.jpg (GRAPHIC) — 315KB
- tproxy_001.jpg (GRAPHIC) — 1571KB
- tproxy_002.jpg (GRAPHIC) — 1293KB
- tproxy_003.jpg (GRAPHIC) — 1130KB
- tproxy_004.jpg (GRAPHIC) — 808KB
- 0001213900-24-001702.txt ( ) — 8622KB
From the Filing
DEF 14A 1 def14a0124_modular.htm PROXY STATEMENT   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________ SCHEDULE 14A ________________ Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant   Filed by a Party other than the Registrant   Check the appropriate box:   Preliminary Proxy Statement   Confidential, for Use of the Commission Only (as permitted by Rule 14a -6 (e)(2))   Definitive Proxy Statement   Definitive Additional Materials   Soliciting Material Pursuant to §240.14a -12 MODULAR MEDICAL, INC. (Name of Registrant as Specified In Its Charter) _________________________________________________________________ (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box):   No fee required.   Fee paid previously with preliminary materials.   Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a -6 (i)(1) and 0 -11 .   Dear Shareholder: We invite you to attend the 2024 Annual Meeting of Shareholders of Modular Medical, Inc. to be held via a live audio webcast on Tuesday, February 13, 2024, at 8:00 a.m. Pacific time. You will be able to attend the Annual Meeting by visiting www.virtualshareholdermeeting.com / MODD2024 . The Notice of the Annual Meeting and Proxy Statement accompanying this letter provide information concerning matters to be considered and acted upon at the meeting. Your vote is important. We encourage you to read all of the information in the Proxy Statement and vote your shares as soon as possible. Whether or not you plan to attend, you can be sure your shares are represented at the Annual Meeting by promptly submitting your vote by the Internet, by telephone or by mail. On behalf of the Board of Directors, thank you for your continued confidence and investment in Modular Medical, Inc. Sincerely,     / s / Paul DiPerna     Paul DiPerna     Chairman of the Board of Directors           First mailed to shareholders on or about January 8, 2024   MODULAR MEDICAL, INC. 10740 Thornmint Road San Diego, CA 92127 (858) 800 -3500 NOTICE OF ANNUAL MEETING OF SHAREHOLDERS TO BE HELD FEBRUARY 13, 2024 To the shareholders of Modular Medical, Inc.: You are cordially invited to attend the Annual Meeting of Shareholders (the “Annual Meeting”) of Modular Medical, Inc., a Nevada corporation (together with its subsidiaries, the “Company,” “Modular Medical,” “we,” “us” or “our”). The Annual Meeting will be held on February 13, 2024, at 8:00 a.m. Pacific time, in a virtual meeting format, for the following purposes: 1.        To elect seven directors to hold office until the next annual meeting of shareholders or until each of their successors are elected and qualified (Proposal No. 1); 2.        To approve the amendment of the Amended 2017 Equity Incentive Plan (the “2017 Plan”) to increase the number of shares available for issuance by 3,000,000 shares (Proposal No. 2); 3.        To approve an amendment of the Articles of Incorporation, as amended, to increase the number of authorized shares of common stock from 50,000,000 shares to 100,000,000 shares (Proposal No. 3); 4.        To ratify the appointment of Farber Hass Hurley LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2024 (Proposal No. 4); 5.        To approve one or more adjournments of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes to approve the foregoing proposals (Proposal No. 5); and 6.        To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof. The foregoing items of business are more fully described in the Proxy Statement, which is attached and made a part of this Notice. Only shareholders of record of our common stock, par value $0.001 per share, at the close of business on December 18, 2023 (the “Record Date”), will be entitled to notice of, and to vote at, the Annual Meeting or any adjournment thereof. You are cordially invited to attend the